A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus

Clinical trial NCT02439957 · TERMINATED

Trial details

NCT number: NCT02439957
Sponsor: Jazz Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus Disease Kidney Transplant Infection

Start date: 2015-09-01
Primary completion: 2016-05-15
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.